Incivek

Positive Interim Data From a Phase 2 Study of INCIVEK™ (telaprevir) Combination Therapy in People Co-Infected with Hepatitis C and HIV Presented at The Liver Meeting®

Positive Interim Data From a Phase 2 Study of INCIVEK™ (telaprevir) Combination Therapy in People Co-Infected with Hepatitis C and HIV Presented at The Liver Meeting®

Yahoo/BusinessWire

Vertex Bests Merck in New Hepatitis C Drug Sales

Vertex Bests Merck in New Hepatitis C Drug Sales

NY Times, NY

Vertex tests shorter Incivek therapy in patient subset

Vertex tests shorter Incivek therapy in patient subset

Fierce Pharma

Vertex CEO sees "historic launch" for Hep-C drug

Vertex CEO sees "historic launch" for Hep-C drug

Reuters

Vertex Declines After Sales of Incivek Are Little Changed

Vertex Declines After Sales of Incivek Are Little Changed

Bloomberg

Hep C Drug Updates: Vertex and Anadys

Hep C Drug Updates: Vertex and Anadys

TheStreet.com

Vertex Shares Rise on Optimism for Higher Incivek Sales

Vertex Shares Rise on Optimism for Higher Incivek Sales

Bloomberg

Can Vertex Catch Lightening in a Bottle Again?

Can Vertex Catch Lightening in a Bottle Again?

Seeking Alpha

More Data on Vertex's Incivek

More Data on Vertex's Incivek

Yahoo/Zacks.com